ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.768,96
0,33%
S&P 500
5.308,13
0,09%
Dow Jones
39.806,77
-0,49%
Euro vs US Dollar
1,08607
-0,13%
Bitcoin
71.198,98
7,43%
Registration Strip Icon for default Registrieren Sie sich kostenlos, um Echtzeitkurse, interaktive Charts, Live-Optionsfluss und mehr zu erhalten.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. Neurochem - Common Shares (MM) (NRMX)

  7. Neurochem - Common Shares (MM) (NRMX) News

NRMX

Neurochem (NRMX)

Neurochem - Common Shares (MM)
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NASDAQ:NRMX
DatumZeitQuelleÜberschriftSymbolFirma
16/04/200817h57Edgar (US Regulatory)Neurochem Inc - Report of Foreign Issuer (6-K)NASDAQ:NRMXNeurochem - Common Shares (MM)
15/04/200814h00PR Newswire (US)At Annual and Special Meeting of Shareholders - Neurochem to officially adopt new name - BELLUS Health - And to provide update oNASDAQ:NRMX
11/04/200822h27Edgar (US Regulatory)Neurochem Inc - Report of Foreign Issuer (6-K)NASDAQ:NRMXNeurochem - Common Shares (MM)
11/04/200820h30PR Newswire (US)Media advisory - Neurochem's Annual and Special Meeting of Shareholders April 15, 2008NASDAQ:NRMX
11/04/200818h24PR Newswire (US)Neurochem Annual and Special Meeting of shareholdersNASDAQ:NRMX
10/04/200817h26Edgar (US Regulatory)Neurochem Inc - Amended Annual Report (foreign private issuer) (40-F/A)NASDAQ:NRMXNeurochem - Common Shares (MM)
20/03/200817h48Edgar (US Regulatory)Neurochem Inc - Report of Foreign Issuer (6-K)NASDAQ:NRMXNeurochem - Common Shares (MM)
14/03/200822h23Edgar (US Regulatory)Neurochem Inc - Report of Foreign Issuer (6-K)NASDAQ:NRMXNeurochem - Common Shares (MM)
14/03/200822h07Edgar (US Regulatory)Neurochem Inc - Annual Report (foreign private issuer) (40-F)NASDAQ:NRMXNeurochem - Common Shares (MM)
13/03/200820h25Edgar (US Regulatory)Neurochem Inc - Report of Foreign Issuer (6-K)NASDAQ:NRMXNeurochem - Common Shares (MM)
13/03/200812h00PR Newswire (US)Neurochem moves eprodisate (KIACTA(TM)) drug development program forward for Amyloid A amyloidosisNASDAQ:NRMX
22/02/200820h10Edgar (US Regulatory)Neurochem Inc - Report of Foreign Issuer (6-K)NASDAQ:NRMXNeurochem - Common Shares (MM)
22/02/200801h19PR Newswire (US)Neurochem announces departure of two members of management teamNASDAQ:NRMX
21/02/200822h54Edgar (US Regulatory)Neurochem Inc - Amended Report of Foreign Issuer (6-K/A)NASDAQ:NRMXNeurochem - Common Shares (MM)
21/02/200821h18Edgar (US Regulatory)Neurochem Inc - Report of Foreign Issuer (6-K)NASDAQ:NRMXNeurochem - Common Shares (MM)
21/02/200801h12PR Newswire (US)Neurochem reports results for fourth quarter and fiscal year 2007 and important advances on corporate objectivesNASDAQ:NRMX
15/02/200821h45Edgar (US Regulatory)Neurochem Inc - Report of Foreign Issuer (6-K)NASDAQ:NRMXNeurochem - Common Shares (MM)
13/02/200818h26PR Newswire (US)/C O R R E C T I O N from source -- Neurochem Inc./NASDAQ:NRMX
11/02/200821h55Edgar (US Regulatory)Neurochem Inc - Report of Foreign Issuer (6-K)NASDAQ:NRMXNeurochem - Common Shares (MM)
11/02/200816h46PR Newswire (US)Neurochem to present at 2008 BIO CEO & Investor Conference - Presentation will be Web cast liveNASDAQ:NRMX
30/01/200822h26Edgar (US Regulatory)Neurochem Inc - Report of Foreign Issuer (6-K)NASDAQ:NRMXNeurochem - Common Shares (MM)
30/01/200814h00PR Newswire (US)Neurochem appoints Mr. Gary Schmid as CEO of new nutraceutical businessNASDAQ:NRMX
03/01/200821h59Edgar (US Regulatory)Neurochem Inc - Report of Foreign Issuer (6-K)NASDAQ:NRMXNeurochem - Common Shares (MM)
03/01/200819h08PR Newswire (US)Neurochem to present at JPMorgan Healthcare ConferenceNASDAQ:NRMX
14/12/200721h51Edgar (US Regulatory)Neurochem Inc - Report of Foreign Issuer (6-K)NASDAQ:NRMXNeurochem - Common Shares (MM)
14/12/200714h24PR Newswire (US)Neurochem announces European opinion for Eprodisate (KIACTA(TM)) for the treatment of AA amyloidosisNASDAQ:NRMX
07/12/200723h25Edgar (US Regulatory)Neurochem Inc - Report of Foreign Issuer (6-K)NASDAQ:NRMXNeurochem - Common Shares (MM)
06/12/200723h09PR Newswire (US)Neurochem announces eprodisate (KIACTA(TM)) receives acknowledgement of complete response and is granted Class 2 reviewNASDAQ:NRMX
03/12/200721h05Edgar (US Regulatory)Neurochem Inc - Report of Foreign Issuer (6-K)NASDAQ:NRMXNeurochem - Common Shares (MM)
30/11/200722h15PR Newswire (US)Neurochem announces departure of Dr. Philippe Calais, President, Global BusinessNASDAQ:NRMX
 Showing the most relevant articles for your search:NASDAQ:NRMX

Kürzlich von Ihnen besucht

NASDAQ
NVDA
NVIDIA
CCOM
US100
US Tech 100
TG
NOV
Novo Nordisk
DBI
DAX
DAX
USOTC
ADDYY
Adidas (QX)
FX
EURGBP
Euro vs Sterling
DBI
SDXP
SDAX
NASDAQ
AAPL
Apple
NYSE
NKE
Nike
FX
EURUSD
Euro vs US Dollar
USOTC
BASFY
BASF (QX)
TG
CBK
Commerzbank
CCOM
SILVER
SILVER
PM
XAUUSD
Gold vs US Dollar
USOTC
RHHBY
Roche (QX)
TG
BAYN
Bayer
Delayed Upgrade Clock
ADVFN Logo

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten